Sharmila Nebhrajani OBE (Shar) is Chairman of the National Institute of Health and Care Excellence (NICE), the organisation that approves the most promising drugs and MedTech for use in the UK NHS, a role at the intersection of complex health economics and challenging ethics. She is also Non-Executive Director at some of the UK’s most well known companies including ITV, Halma and Severn Trent plcs, having built her career across media healthcare and public policy. 

On behalf of the King and the Chancellor of the Exchequer she chairs the Sovereign Grant Audit and Risk committee and is a NED on the Lord Chamberlain’s Committee of the Royal Household. Her other NED appointments include the Governing Council of Oxford University and the boards of Genomics England and the Thomson Reuters Founders Share Company.  

Sharmila studied Medicine at the University of Oxford, is a World Fellow at the University of Yale and was appointed an OBE for services to medical research. She began her career in strategy consulting for PwC where she also qualified as a Chartered Accountant.